Introduction
The long cytoplasmic tail (CT) of the envelope glycoprotein is one of the unique characteristics of lentiviruses which distinguish them from other retroviruses. For HIV the gp41 cytoplasmic tail is approximately 150 amino acids long and is highly conserved. It plays an important role in the incorporation of envelope proteins into virions, during maturation, and modulates viral infection in a cell type specific manner (Akari et al., 2000; Celma et al., 2001; Day et al., 2004; Dubay et al., 1992; Freed and Martin, 1996; Iwatani et al., 2001; Piller et al., 2000; Wilk, et al., 1992; Wyma et al., 2004) . The interaction of gp41 CT with gagPr55 has been described experimentally (Egan et al., 1996; Hourioux et al., 2000; Murakami and Freed, 2000; Vincent et al., 1999; Wyma, et al., 2000) and recently shown to interfere with envelope incorporation (Chan and Chen, 2007) .
Although a number of cellular interaction partners for the HIV cytoplasmic tail have been described (Blancou et al., 2005; Evans et al., 2002; Ishikawa et al., 1998; Kim et al., 1999; Micoli et al., 2006; Srinivas et al., 1993; Tencza et al., 1997; Tencza et al., 1995; Yuan et al., 1995 Yuan et al., , 2001 Zhang et al., 1999) , the effect of expression of these tails in infected cells on de novo infection or viral superinfection has not been addressed. Apart from receptor and co-receptor modulation, the role of the cytoskeleton in HIV infection is of particular interest. The cytoskeleton is involved in the early events of viral infection, regulating viral fusion and the movement of viral structures like the pre-integration complex of HIV (Fackler and Krausslich, 2006; Pelkmans, 2005) . Recently, Valenzuela-Fernandez et al. (Valenzuela-Fernandez et al., 2005) identified microtubules and their posttranslational modifications as a key regulator for viral infection. Interaction of the outer envelope protein gp120 with CD4 induces an Virology 376 (2008) [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] increase of acetylated tubulin and thus more stable microtubules, resulting in more efficient infection. Reducing the levels of acetylated tubulin in target cells was shown to reduce virus infection.
In this study we analyzed the effect of target cell expressed cytoplasmic tails on viral infection and show that HIV-1 and HIV-2 cytoplasmic tails reduce virus-cell fusion by reducing the levels of acetylated tubulin. Furthermore, the reduction of virus-cell fusion was shown to be entry route dependent since VSV-G mediated fusion was not affected by the expression of gp41 cytoplasmic tails in target cells. In addition, T cells stably expressing an HIV cytoplasmic tail construct were analyzed and showed a reduced level of acetylated tubulin and reduced HIV-1 replication kinetics. Together these results identify lentiviral cytoplasmic tails as a new factor involved in reducing virus infection which, along with gp120 and the accessory proteins Vpu and Nef, may play a role in the restriction of superinfection (Wildum et al., 2006) .
Results

Expression of HIV proviral constructs in HeLaP4 and 293T cells reduces acetylated tubulin and interferes with virus-cell fusion
Binding of gp120 to target cells via CD4 has been shown to increase the level of acetylated tubulin and to enhance viral infection whereas reducing the level of acetylated tubulin through over expression of the histone-deacetylase HDAC6 resulted in reduced viral infection (Valenzuela-Fernandez et al., 2005) . These observations prompted us to study the effect of HIV expression on the levels of acetylated tubulin.
To address this question plasmids encoding full-length HIV-1 were transfected into HeLaP4 and 293T cells. HIV-1 NL4.3 , HIV-1 NL-A1(CD4−) , and HIV-1 NLΔCT were used and changes in acetylated tubulin quantified. While HIV-1 NL4.3 encodes for an envelope protein that can bind CD4 and subsequently facilitates infection of HeLaP4 cells, HIV-1 NL-A1(CD4−) is deficient in CD4 binding. HIV-1 NLΔCT lacks the cytoplasmic tail of gp41 but encodes an envelope protein that binds CD4 and infection of HeLaP4 cells is possible. HeLaP4 and 293T cells were transfected with the proviral constructs and the levels of tubulin and acetylated tubulin determined ( Fig. 1A) . As Fig. 1B shows the transfection of HIV-1 NL4.3 resulted in a slight increase of acetylated tubulin in HeLaP4 cells (115.4 ± 10.5%) which correlates with the findings of Valenzuela-Fernandez et al. (Valenzuela-Fernandez et al., 2005) . NL4.3 gp120 binding to neighbouring HeLaP4 cells induces an increase in acetylated tubulin. For HIV-1 NL-A1(CD4−) expressed in HeLaP4 cells no change in acetylated tubulin was expected since gp120 expressed in transfected cells cannot bind CD4 on neighbouring cells to induce a higher level of acetylated tubulin. However, the expression of HIV-1 NL-A1(CD4−) resulted in a significant reduction of acetylated tubulin (54.2 ± 4.4% relative to non-transfected cells). This substantial reduction was not observed for the expression of HIV-1 NLΔCT in HeLaP4 cells (97.5 ± 1.5%) indicating the cytoplasmic tail of gp41 in the modulation of tubulin acetylation.
In order to avoid interference of gp120/CD4-induced changes in acetylated tubulin, transfected 293T cells were also analyzed. For both HIV-1 NL4.3 and HIV-1 NL-A1(CD4−) a significant reduction in acetylated tubulin was detected (62.8 ± 12.3% and 60.7 ± 10.5%, respectively). This reduction however was not observed when the construct with a deleted cytoplasmic was transfected. HIV-1 NLΔCT expression did not affect the level of acetylated tubulin in 293T cells (102.6 ± 8.9%). Together these results indicated that the cytoplasmic tail expressed in HeLa and 293T cells down-modulates acetylated tubulin and thus has the opposite effect to gp120 binding CD4 prior to infection as described by Valenzuela-Fernandez et al. (Valenzuela-Fernandez et al., 2005) .
Expression and localization of the cytoplasmic tail constructs
In order to study the role of cytoplasmic tails in HIV target cells different cytoplasmic tail-expressing constructs (envCT) were generated (Fig. 2) . The control construct consisting only of the myc-and HAtags and the transmembrane domain (TMD) of the platelet derived growth factor receptor (PDGFR) and no intracellular peptide region (anchor) localizes clearly to the plasma membrane. The full-length cytoplasmic tails of HIV-1 (HIV-1/fl) and HIV-2 (HIV-2/fl) localize mainly to the plasma membrane but can also be found in endosomal vesicles. The truncated versions of both tail constructs (HIV-1/tr and HIV-2/tr) show a more pronounced localization to the plasma membrane due to the loss of the dileucine based endocytosis signal located in the C-terminus of cytoplasmic tail (Berlioz-Torrent et al., 1999; Bowers et al., 2000; Bultmann et al., 2001; Sauter et al., 1996; Wyss et al., 2001) . In addition, a 'soluble' (no TMD) truncated HIV-2 tail (HIV-2/sol) was generated and analyzed. HIV-2/sol localizes predominantly in the cytoplasm. Furthermore, the short cytoplasmic tail of the Moloney Leukemia Virus (MLV-CT) was expressed from a plasmid encoding the HA-/myc-tag and the PDGFR transmembrane domain. This mini-protein shows a pronounced plasma membrane association similar to that of the control construct (anchor) and the shortened tails of HIV-1 and HIV-2 (HIV-1/tr and HIV-2/tr).
Expression of cytoplasmic tail constructs in HeLaP4 cells reduces acetylated tubulin and interferes with virus-cell fusion
HeLaP4 cells were transfected with the described cytoplasmic tail constructs and analyzed for the expression of tubulin and the amount of acetylated tubulin. As Fig. 3A shows all lentiviral derived cytoplasmic tail constructs reduced the level of acetylated tubulin significantly (HIV-1/fl: 21.6 ± 1%; HIV-1/tr: 27.4 ± 1.1%; HIV-2/fl: 25.3 ± 5.8%; HIV-2/tr: 47.5 ± 5.9% relative to non-transfected cells). The soluble construct (HIV-2/sol) showed a less pronounced effect compared to the other cytoplasmic tail constructs but still reduced the level of acetylated tubulin by 51.3 ± 5.8%. The anchor construct used as negative control showed no significant effect on the amount of acetylated tubulin as did the MLV-CT construct (anchor 89.6 ± 19.3% and MLV-CT 72.7 ± 12.7).
To confirm that the cells expressing the cytoplasmic tail constructs are those containing less acetylated tubulin, individual transfected or mock transfected cells were analyzed. In Fig. 4 representative pictures of transfected HeLaP4 cells are shown. HeLaP4 cells expressing the construct HIV-2/tr (green) showed a marked reduction of acetylated tubulin (red) compared with non-transfected cells (8.3 ± 1.2%). In contrast, transfection of the anchor construct did not affect acetylated tubulin levels ( Fig. 4C ).
Next, the fusion efficiency of virions pseudotyped with different viral envelope proteins with HeLaP4 cells expressing the cytoplasmic tail constructs was analyzed. Pseudotyped virions carrying the envelope protein of HIV-1 NL4.3 , MLV (amphotroph) or VSV-G together with the Blam-vpr fusion protein were generated ( Fig. 3B ). Mock Localization of cytoplasmic tail constructs. A) Schematic depiction of the generated cytoplasmic tail constructs. All constructs contain an extracellular HA-and myc-tag at their N-terminus. The transmembrane domain (TMD) was derived from the platelet derived growth factor receptor (PDGFR). The cytoplasmic tails were cloned from HIV-1, HIV-2 and MLV envelope encoding vectors and the full-length constructs (HIV-1/fl; HIV-2/fl) contain the lentiviral lytic peptides 1 and 2 and the leucine zipper domain (LLP1, LLP2, LZ, respectively). Both endocytosis signals (YxxΦ and LL) are present in these constructs as depicted in the overview. The truncated versions HIV-1/tr and HIV-2/tr lack LLP1, LLP2, LZ and the dileucine dependent endocytosis signal located in that region (LL). B) Localization of the cytoplasmic tail constructs in transiently transfected HeLaP4 cells. Cells were transfected with the constructs and stained for confocal microscopy analysis 48 h post transfection. transfected cells were used as a positive control and infection in those cells was set to 100% for normalization. The anchor construct used as a negative control showed no effect irrespective of the pseudotyped virion assayed, whereas all envCT-constructs derived from HIV-1 and HIV-2 (HIV-1/fl and HIV-1/tr; HIV-2/fl and HIV-2/tr) significantly reduced viral fusion of NL4.3 envelope and MLV envelope pseudotyped virions. The reduction in fusion efficiency was slightly more pronounced for the HIV-2 constructs (HIV-2/fl: 47.9 ± 9.6%; HIV-2/tr: 53.3 ± 5.4% relative to non-transfected cells) compared to the HIV-1 constructs (HIV-1/fl: 59.7 ± 5.2%; HIV-1/tr 53.4 ± 2.6% relative to nontransfected cells). Cells expressing the 'soluble' HIV-2 tail construct (HIV-2/sol) showed a reduction of fusion comparable to that of the plasma membrane bound construct HIV-2/tr (45.2 ± 16.6%). Similar results were obtained for the MLV-cell fusion assay. Interestingly, expression of the MLV cytoplasmic tail did not interfere with viruscell fusion for NL4.3 and MLV envelope pseudotyped virions. None of the envCT-constructs conferred a reduction in virus-cell fusion for VSV-G pseudotyped virions. These results confirm the correlation between acetylated tubulin and virus infection as observed by Valenzuela-Fernandez et al. (Valenzuela-Fernandez et al., 2005) and identifies virus-cell fusion at the plasma membrane as the main step at which modulation of acetylated tubulin interferes with HIV and MLV infection. Only the lentiviral cytoplasmic tails modulate the level of tubulin acetylation and restrict retrovirus-cell fusion but not VSV-G mediated virus-cell fusion. In addition, the domain necessary for the inhibition of fusion was identified and is located in the membrane proximal part of gp41-CT.
Identification of cytoplasmic tail motifs conferring reduced levels of acetylated tubulin and reduced virus-cell fusion
In order to identify the specific motifs required to modulate acetylated tubulin and thus effect virus-cell fusion, alanine mutations were introduced along the 45 amino acids of the cytoplasmic tail for construct HIV-2/tr. Fig. 5A depicts the sequence and the location of the alanine mutations for the mutant constructs mut1 to mut8 which were generated by site-directed mutagenesis. Localisation of those envCT variants did not differ from the localisation of HIV-2/tr with the exception of mut8 showing a cytoplasmic localisation similar to HIV-2/sol ( Fig. 5B, see Fig. 2 for comparison). First, HelaP4 cells were transfected with these mutant constructs and changes in acetylated tubulin compared to the parental construct HIV-2/tr ( Fig. 5C ) were determined by Western blot. The first three mutant constructs contain alanine changes close to the tyrosine-based endocytosis signal YXXΦ, located just after the transmembrane domain. While mut1 (60.2% ± 10.1%) did reduce the level of acetylated tubulin significantly, mut2 (100.9% ± 14.7%) and mut3 (82.3 ± 26.6%) had lost the capability to reduce acetylated tubulin in transfected HeLaP4 cells. For construct mut4 (64.4% ± 4.7%), its expression in HelaP4 cells reduced acetylated tubulin as strongly as the parental construct HIV-2/tr (47.5 ± 5.9%) whereas the mutations in constructs mut5 to mut8 all abrogated the phenotype to different extents (mut5: 93.7% ± 15.9%, mut6: 105.2 ± 17.1%, mut7: 72.0% ± 21.5%, mut8: 108.9% ± 26.8%). These findings indicate that there are three potential motifs in the membrane proximal region of the gp41 cytoplasmic domain which are of importance for the down modulation of acetylated tubulin.
Next, changes in virus-cell fusion were analyzed using a subset of the mutant constructs (mut1, mut2, mut6 and mut8). Transfected HeLaP4 cells were infected with NL4.3 or VSV-G envelope pseudotyped, Blam-vpr carrying virions and a virus-cell fusion assay was performed. The results obtained reflect those of the Western blot assays to detect changes in acetylated tubulin. While mut1 reduces virus-cell fusion to 61.2 ± 11.6%, the three mutants abrogating the acetylation phenotype also lost the capability to reduce virus-cell fusion (mut2: 98.5 ± 13.2%, mut6: 97.9 ± 15.2% and mut8: 95.8 ± 12%) ( Fig. 5D ). Again a strong correlation between levels of acetylated tubulin and virus-cell fusion was observed, suggesting the membrane proximal domain of the gp41 cytoplasmic domain contains three motifs capable of interfering with virus-cell fusion.
T-cells stably expressing HIV-2/tr show reduced susceptibility to HIV-1 replication
To include a more relevant target cell into our study we stably transduced the T cell line PM1 and selected for the expression of HIV-2/tr and the anchor construct as control cells (PM1/anchor, PM1/HIV-2/tr). A cell viability assay was performed and the expression levels of CD4 and CXCR4 determined. Both cell lines showed similar growth kinetics and expression levels for both CD4 and CXCR4 (data not shown). The anchor and HIV-2/tr envCT-constructs localized to the plasma membrane of PM1 cells. Next, the PM1 cells were analyzed for the expression of acetylated tubulin (Fig. 6A) . The HIV-2/tr expressing T-cells show a highly significant reduction of acetylated tubulin (64.8 ± 12.4%) compared with PM1/anchor cells and the parental PM1 cells, indicating that the envCT-construct interferes with post-translational modifications of tubulin not only in HeLaP4 cells but also human lymphocytes. Moreover, a reduced level of acetylated tubulin can be tolerated in T-cells. In Fig. 6B the effect of the cytoplasmic tail constructs on viral replication of HIV-1 NL4.3 is depicted. While PM1 cells expressing the anchor construct allow HIV-1 replication to a similar extent as the parental PM1 cells, the PM1/HIV-2/tr cells show a reduced replication kinetic (2-3 fold less p24 at days 16 to 25 post infection). Thus, the expression of the cytoplasmic tail in T-cells does not affect cell viability but reduces the level of acetylated tubulin and thus HIV-1 replication.
Modulation of acetylated tubulin levels independent of HIV derived constructs
The modulation of acetylated tubulin levels in cells can be achieved by over expression of proteins involved in the regulation of microtubule stability as well as by using compounds known to interfere with tubulin deacetylation. As previously described, the histone-deacetylase HDAC6 is a regulator of tubulin acetylation and itself is regulated through a RhoA dependent pathway (Destaing et al., 2005) . In order to study the effect of over expression of HDAC6 and RhoV14, a constitutively active form of RhoA, HeLaP4 cells were transfected and quantitative Western blots and virus-cell fusion Fig. 4 . Single cell analysis of HIV-2/tr transfected HeLaP4 cells for acetylated tubulin. HeLaP4 cells were transfected with the HIV-2 truncated cytoplasmic tail (A) and the anchor construct (B) as described above. 48 h post transfection cells were stained for the tail construct (FITC-anti-HA), acetylated tubulin (anti-acetylated-tubulin/anti-mouse-Alexa568) and total tubulin (anti-tubulin/anti-mouse-Alexa568) and analyzed using a Nikon CiS1 confocal microscope. C) Pixel intensity for stained tubulin and acetylated tubulin signals was determined for 30 cells per construct and experiment. ImageJ software was used as described in Materials and methods. The results of three independent experiments are summarized and error bars depict the standard deviation. assays were performed. Over expression of RhoV14 and HDAC6 resulted in a significant reduction of acetylated tubulin (49.4 ± 4.9% and 9.4 ± 1.5%, respectively) ( Fig. 7A, upper panel) . As observed after expression of the HIV envCT-constructs, decreased levels of acetylated tubulin resulted in reduced virus-cell fusion for NL4.3 (RhoV14: 49.2 ± 8.4%, HDAC6: 49.8 ± 1.7%) and MLV envelope pseudotyped virions (RhoV14: 40.5 ± 1.5%, HDAC6: 53.0 ± 3.9%) but not for VSV-G pseudotyped virions (Fig. 7B, upper panel) . However, the 10-fold reduction in acetylated tubulin after HDAC6 transfection yielded only a maximum 2-fold reduction in virus-cell fusion. Incubation of HeLaP4 cells with tubacin and TSA resulted in a 11.7-fold (tubacin) and 4.1-fold (TSA) increase in acetylated tubulin, correlating with increased infection as measured by a single cell infection assay using NL4.3 envelope pseudotyped virions (224.4 ± 53.4% and 202.2 ± 54.9%, respectively, Figs. 7A and B, lower panel) . Again, although an 11.7-fold increase of acetylated tubulin could be detected, a maximal 2-fold increase in virus-cell fusion was observed.
Discussion
Host cell cytoskeletal structures present a physical barrier to viruses during cell entry. For human retroviruses the plasma membrane constitutes the predominant site of fusion, whereas other viruses such as vesicular stomatitis virus (VSV) exploit the endosomal machinery for efficient fusion (Fackler and Krausslich, 2006; Marsh and Helenius, 2006) . Surprisingly little is known about the mechanism by which viruses such as HIV use cytoskeletal dynamics to facilitate virus-cell fusion. Recently, Valenzuela-Fernandez and colleagues described the role of the histone-deacetylase type 6 (HDAC6) in modulating microtubule stability through the deacetylation of tubulin. The authors showed reduced infection and cell-cell fusion after overexpression of HDAC6 in HIV target cells. Furthermore, they demonstrated that soluble gp120 induces higher levels of acetylated tubulin via binding to CD4 suggesting that an increased level of acetylated tubulin is advantageous to virus infection (Valenzuela-Fernandez et al., 2005) .
Using a CD4-binding deficient proviral plasmid and a plasmid encoding for an envelope protein lacking the cytoplasmic tail of gp41 we confirmed that gp120/CD4 interaction is indeed required to increase the level of acetylated tubulin but more importantly, that the cytoplasmic tail is responsible for the reduction of acetylated tubulin in transfected cells (Fig. 1 ). To study this newly observed phenotype in more detail, several mini-proteins were constructed using a membrane anchor encoding plasmid containing epitope tags at the N-terminal end. All HIV derived envCT-constructs led to the reduction of acetylated tubulin in HeLaP4 cells whereas the MLV cytoplasmic tail encoding construct did not interfere with the post-translational modification of tubulin (Figs. 2 and 3 ). This indicates a lentiviral or human cell specific mechanism as the same results were obtained using 293T cells (data not shown). Single cell analyses confirmed that the observed reduction in acetylated tubulin is dependent on the expression of the envCT-constructs. Transduction of the anchor construct and HIV-2/tr into the T-cell line PM1 also revealed a significant reduction in the level of acetylated tubulin, supporting the notion that its effect on cytoskeletal structures is an important feature of lentiviral cytoplasmic tails expressed in HIV target cells. Interestingly, the growth kinetics of the stable T-cell line did not change due to the expression of the cytoplasmic tail construct or the reduced level of acetylated tubulin (data not shown).
Our studies using a number of truncated and soluble forms of the envCT-constructs clearly demonstrate that the observed reduction in acetylated tubulin is independent of lentivirus-lytic-peptide domains (LLP1 to LLP3) and not mediated through plasma-membrane localization. The recently described interaction domain of gp41 CT with the transcription factor luman (Blot et al., 2006) is partly present in the truncated cytoplasmic tail construct HIV-1/tr and this construct confers a reduction in fusion efficiency of 53.4 ±2.6% relative to mock transfected cells. However, luman localizes to the ER or, upon activation, to the nucleus and thus is unlikely to be responsible for the observed phenotype.
To further delineate the motif/s responsible for the reduction of acetylated tubulin a series of alanine mutants was tested and three regions in the truncated HIV-2 cytoplasmic tail were identified. Mutations close to the YxxΦ endocytosis signal abrogated the phenotype (mut2 and mut3) as did those in the c-terminal end (amino acid 21 to 45 of the cytoplasmic tail in HIV-2/tr) of the truncated cytoplasmic tail (mut5 to mut8). It has been described that the YxxΦ motif is needed to mediate clathrin-dependent endocytosis of the envelope protein via interaction with AP-1 and AP-2 (Byland et al., 2007) . The second motif identified corresponds to a more variable region of both HIV-1 and HIV-2 cytoplasmic tails. Interestingly, amino acids 30 to 35 in HIV-2 (EETEED) are highly conserved while the flanking sequences are responsible for the high variability observed between HIV-2 subtypes A and B. The same is true for HIV-1 (amino acids 26-31: EEEGGE) whereas this motif is not present in the MLV cytoplasmic tail. The studied alanine mutations in the HIV-2/tr construct do not affect the EETEED motif but introduce changes in the Fig. 6 . Effects of the cytoplasmic tail construct HIV-2/tr stably expressed in the T-cell line PM1. A) PM1 cells were lysed and analyzed by Western blot for total tubulin and acetylated tubulin. Three independent experiments are summarized. Error bars show the standard deviation. The significance of the values was evaluated by the Student's t-test (⁎⁎ = p b 0.001). B) PM1 cells were infected with a replication competent HIV-1 NL4.3 (MOI = 0.1) and virus replication monitored until day 25. One representative result out of three independent challenge experiments is shown. Fig. 7 . Interference with the tubulin modifications and effect on virus-cell fusion and single-round infection. A) HeLaP4 cells were either transiently transfected with HDAC6-GFP or RhoV14 or treated with the inhibitors tubacin or TSA for 1 h. Changes in the ratio of acetylated tubulin to total tubulin were calculated from Western blot results. Cells were lysed and used for Western blotting. The upper panel shows the results for the transfections, the lower panel shows the effect of the inhibitors on the acetylation of tubulin. B) HeLaP4 cells were either transiently transfected with HDAC6-GPP or RhoV14 24 h prior to infection with NL4.3 envelope pseudotyped particles or incubated with tubacin or TSA 1 h prior to infection. The transfected cells were analyzed using the virus-cell fusion assay while the cells treated with the inhibitors were analyzed with a single-round-infection assay. Both panels show mean values of three independent experiments and standard deviations are depicted by the error bars. Significance was evaluated by Student's t-test as described in A.
surrounding not present in any HIV-2 sequence according to the Los Alamos database. It is tempting to speculate that these changes interfere with the accessibility of the EETEED motif for a yet to be identified cellular factor. The third identified motif located to the very end of the truncated tail (mut8). Changing the two terminal serine residues to alanine abrogates the effect on acetylated tubulin and virus-cell fusion although this construct locates in the cytoplasma as does HIV-2/sol. Future experiments using HIV-2/tr and one of the mutant constructs described will identify cellular factors involved and allow delineation of the mechanism responsible for changes in acetylated tubulin levels and virus-cell fusion.
Since the level of acetylated tubulin can modulate HIV infection, we studied the effect these envCT-constructs have on virus-cell fusion. We demonstrate that virus-cell fusion is impaired in cells expressing HIV-1 and HIV-2 cytoplasmic tails. This reduction was seen for HIV-1 and MLV envelope pseudotyped particles but not for VSV-G pseudotyped particles on HeLaP4 cells and for HIV replication in the transduced T-cell line PM1 (Figs. 3 and 6 ). Our data on the susceptibility of T-cells stably expressing the cytoplasmic tail construct HIV-2/tr clearly show, that the envCT-mediated effect can be observed not only in HeLaP4 cells but also in more relevant HIV target cells (Fig. 6 ). The expression of cytoplasmic tails in HeLaP4 cells specifically interferes with virus fusion at the plasma membrane and not from endosomal membranes. Remarkably, the effect is specific for lentiviral tails because expression of a heterologous MLV cytoplasmic tail had no effect on viral fusion. The endosomal pathway (VSV-G mediated fusion) is not affected. It has been shown that HIV and MLV envelope mediated infection occurs via endosomal and/or caveolae uptake (Beer et al., 2005; Daecke et al., 2005) in addition to fusion at the plasma membrane. Whether the 2-3 fold reduction described here reflects fusion from endosomal membranes or the presence of another pathway independent of microtubule stability needs to be defined. The screening system described here will be useful to address this question in the future.
The reduction in acetylated tubulin after transfection of envCTconstructs is comparable to that observed when a constitutively active form of RhoA (RhoV14) is over expressed in cells (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003) . Again, our results confirm the findings by Valenzuela-Fernandez et al. (Valenzuela-Fernandez et al., 2005) and Wang et al. (Wang et al., 2000) and identify the fusion step as the main target for inhibition of infection through the modulation of acetylated tubulin levels in cells (Fig. 7) . There are conflicting data regarding the role of RhoA on HIV-1 replication. Del Real et al. described inhibition of cell-cell fusion in the presence of a dominant negative form of RhoA (del Real et al., 2004) , whereas Wang et al. showed that activation of RhoA inhibited HIV-1 infection via a pathway distinct from its effects on actin stress fiber formation (Wang et al., 2000) . The latter results support our suggestion of a RhoA/mDia/ HDAC6 pathway, however more experiments are needed to clarify the role of RhoA. Using small molecules to inhibit HDAC6 in HIV target cells we observed a strong increase in acetylated tubulin but only a 2 fold increase in viral infection as measured using a single-round infection assay. Over expression of HDAC6 resulted in a 10 fold reduction of acetylated tubulin but only a 2 fold decrease in virus-cell fusion. This indicates that the modulation of acetylated tubulin only achieves a 2 fold reduction in infection. However, interfering with the microtubule stability due to tubacin treatment or HDAC over expression could have resulted in less viable cells in our assay system thus overestimating the effect on acetylated tubulin. Further studies with careful titration of tubacin or similar drugs known to interfere with microtubule stability will give further insight into the achievable magnitude of inhibition of virus-cell fusion.
Although the reduction in fusion efficiency is more pronounced in cytoplasmic tail transfected HeLaP4 cells compared with the reduced replication kinetic in PM1/HIV-2/tr cells, both results, argue for tubulin or post-translational modifications of tubulin, such as acetylation, being novel cellular targets for prevention of HIV infection at a very early stage. Compounds that stabilize or destabilize microtubules have been identified and are being evaluated in clinical trials as anti cancer drugs (Hideshima et al., 2005; Mani et al., 2004) . Whether those compounds exert potent anti-viral activity through interference with the HIV-cell fusion step remains to be tested.
Materials and methods
Antibodies
The following antibodies were used for this study: monoclonal mouse anti α-tubulin antibody (clone DM-1A, Santa Cruz, Germany), mouse anti-acetylated tubulin antibody (clone 6-11B-1, Sigma, Germany), monoclonal FITC-conjugated anti-HA antibody (Santa Cruz, Germany), monoclonal anti-HA antibody (Roche, Germany), polyclonal Alexa568-conjugated anti-mouse antibody (Molecular Probes, Germany), polyclonal goat anti-mouse PO (Jackson, Great Britain).
Plasmids and cell lines
Mini proteins containing an HA-and myc-tag and the transmembrane domain (TMD) of platelet derived growth factor receptor (PDGFR) derived from pDisplay (Invitrogen, Germany) and the cytoplasmic domains of HIV-1 NL4.3 (U26942.1; full-length: aa687-aa841; truncated: aa687-aa731), HIV-2 CBL23 (full-length: aa697-aa859: LRKGYRPVFSSPPGYLQQIHIHKDWEQRAREETEEDVGNNVGDSSWPWPIRY-IHFLIHQLIRLLTGLYNICRNLL SRISLTLRPVFQSLQRALTAIRDW-LRTDAAYLQRIGRGILAVPRRIRQGAEIALL; truncated: aa697-aa741: LRKGYRPVFSSPPGYLQQIHIHKDWEQRAR EETEEDVGNNVGDS) and MLV (J02255, aa626-aa658) were expressed from the TO/4 vector (Invitrogen, Germany). The HIV-2 soluble protein was generated by deletion of the transmembrane domain of pDisplay. Point mutations to identify motifs in HIV-2/tr (mut1 to mut8) were introduced using the QuikChange XL site-directed mutagenesis kit (Stratagene, Germany) and confirmed by sequence analysis. The vectors pNL-3K, pA1-CD4and pNL-ΔCT have been described (Dittmar et al., 1999; Strebel et al., 1987; Wilk et al., 1992) . HIV-1 NL-A1(CD4−) carries a 12 amino acid deletion in the gp120 CD4 binding region preventing CD4 binding and gp120/CD4 mediated signalling due to conformational changes of the outer envelope. HIV-1 NLΔCT encoded a premature stop codon at amino acid 712 in the envelope open reading frame resulting in the truncation of the gp41 cytoplasmic domain (Wilk et al., 1992) . pRhoV14 (Muller et al., 1997) and pLZR-hHDAC6 (Valenzuela-Fernandez et al., 2005) were previously described.
HeLaP4, a HeLa derivative expressing CD4, and 293T cells were grown in DMEM supplemented with 10% FCS, 100 U/ml penicillin/ streptomycin and 4 mM glutamate. PM1 cells were grown in RPMI 1640 supplemented with 10% FCS and 100 U/ml pen/strep. PM1 cells stably expressing the anchor or the HIV-2 truncated tail were generated through transduction with retroviral vectors encoding for the anchor construct or HIV-2/tr together with eGFP and sorting for eGFP expressing cells.
Western blot
Mock transfected HelaP4 cells and HelaP4 cells transfected with the CT-constructs were lysed 48 h post transfection. Cell lysates were subsequently loaded on a 14% SDS-polyacrylamide gel, transferred and tubulin and acetylated tubulin were detected using appropriate antibodies. For visualization a goat anti-mouse-antibody conjugated to horseradish peroxidase was used in a 1:5000 dilution. The films were quantified using 'quantity one' software and the ratios of acetylated tubulin to total tubulin were calculated for all samples. The ratio of acetylated tubulin to total tubulin for non-transfected cells was set to 100%. PM1 cells were assayed in the same way.
Virus-cell fusion assay (BlaM-assay)
293T cells were transfected with pCMVΔ8.74, pHRCMV-GFP (Naldini et al., 1996) , Blam-vpr1 and one of the envelope protein-encoding plasmids MP11-NL, M3-VSV-G or pAmpho/Env with polyethylenimine (1 mg/ml). 72 h post transfection pseudotyped virions were harvested and purified by ultracentrifugation through a 20% sucrose cushion. HeLaP4 cells were seeded at 1× 10 4 per well in 24-well plates on coverslips and transfected with the plasmids encoding the cytoplasmic tailconstructs. 24 h post transfection cells were infected with the pseudotyped virions for 4 h, and subsequently stained with CCF2 as described (Cavrois et al., 2002) . Virus-cell fusion was analyzed using either an Olympus IX70 microscope or a BD-LSR1-FACS. For each independent microscopic experiment approximately 800 cells were counted while for the FACS based assays 20,000 cells per experiment were analyzed.
Single round infection assay
HeLaP4 cells were used for single-round infections using pseudotyped particles based on the TN7 stopp vector combined with the MP11-NL vector as described previously (Lohrengel et al., 2005) . Cells were lysed 2 days post infection and Renilla luciferase activity was measured using the Renilla Assay system (Promega, Germany).
Microscopy and FACS analysis
HeLaP4 cells were transfected with the plasmids encoding the cytoplasmic tail constructs and stained with a FITC-conjugated anti-HA-antibody to visualize the cellular localization of the proteins. To analyze the influence of the tails on acetylated tubulin at a single cell level the cells were double stained with FITC-conjugated anti-HAantibody and anti-α-tubulin/acetylated tubulin antibody. The latter was visualized by a secondary anti-mouse-Alexa568 antibody. The cells were analyzed using a C1Si confocal microscope (Nikon). To quantify the amount of tubulin and acetylated tubulin in single cells, image stacks of 30 transfected and 30 non-transfected cells per assay were taken and the pixel intensity of each slide measured using ImageJ software (NIH). The mean protein expression in 30 cells was determined for non-transfected and transfected cells and the amount of tubulin/acetylated tubulin in non-transfected cells was set to 100%.
Replication assay
Parental PM1 cells or stably transduced PM1 cells (1 × 10 6 ) were infected with HIV-1 NL4.3 derived from transfections of 293T cells at an MOI of 0.01. After 4 h the cells were washed three times with PBS. At days 2 to 25 post infection p24 in the medium was measured by a standard ELISA-assay (Dittmar et al., 2001) .
